scispace - formally typeset
C

Colleen A. McHorney

Researcher at Merck & Co.

Publications -  94
Citations -  26694

Colleen A. McHorney is an academic researcher from Merck & Co.. The author has contributed to research in topics: Health care & Item response theory. The author has an hindex of 46, co-authored 94 publications receiving 25191 citations. Previous affiliations of Colleen A. McHorney include Medical College of Wisconsin & University of Wisconsin-Madison.

Papers
More filters
Journal ArticleDOI

IRT health outcomes data analysis project: an overview and summary.

TL;DR: Four lessons learned from the project are discussed: the importance of good developmental item banks, the ambiguity of model fit results, the limits of knowledge regarding the practical implications of model misfit, and the importance in the measurement of HRQOL of construct definition.
Journal ArticleDOI

Effects of depression and pain severity on satisfaction in medical outpatients: Analysis of the Medical Outcomes Study

TL;DR: Both minor and major depression as well as pain severity were strongly associated with lower satisfaction scores, and increased age and diagnosis of heart failure predicted higher satisfaction scores.
Journal ArticleDOI

Impact of once- or twice-daily dosing frequency on adherence to chronic cardiovascular disease medications: A meta-regression analysis.

TL;DR: Patients appear to be more adherent to cardiovascular disease medications dosed once-daily compared to twice-daily, and dosing frequency may be a factor for providers to consider when selecting an agent to prescribe.
Journal ArticleDOI

“Practicing medicine”: Patient perceptions of physician communication and the process of prescription

TL;DR: The theory generated here includes patient assessments of their physician's credibility (trustworthiness and expertise) as a critical influence in how chronically-ill patients process information about the need for prescribed therapy.
Journal ArticleDOI

Persistence across weekly and monthly bisphosphonates: analysis of US retail pharmacy prescription refills.

TL;DR: Month dosing does not appear to be associated with improvements in patient persistence with oral bisphosphonates for patients newly initiated on bisph phosphonates.